EU: Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes 2024

Market Size for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in the EU

In 2023, the EU market for hormones, prostaglandins, thromboxanes and leukotrienes increased by X% to $X, rising for the second year in a row after two years of decline. Over the period under review, consumption posted a tangible expansion. The level of consumption peaked at $X in 2014; however, from 2015 to 2023, consumption failed to regain momentum.

Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes in the EU

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes production soared to $X in 2023 estimated in export price. Over the period under review, production recorded a resilient increase. The pace of growth was the most pronounced in 2013 with an increase of X% against the previous year. The level of production peaked at $X in 2014; however, from 2015 to 2023, production failed to regain momentum.

Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

Exports in the EU

In 2023, overseas shipments of hormones, prostaglandins, thromboxanes and leukotrienes increased by X% to X tons, rising for the second year in a row after two years of decline. In general, exports enjoyed buoyant growth. The growth pace was the most rapid in 2019 when exports increased by X% against the previous year. As a result, the exports attained the peak of X tons. From 2020 to 2023, the growth of the exports remained at a lower figure.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports skyrocketed to $X in 2023. Total exports indicated a remarkable increase from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, exports increased by X% against 2020 indices. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

Exports by Country

Ireland dominates exports structure, recording X tons, which was near X% of total exports in 2023. Belgium (X tons), Italy (X tons), Spain (X tons), Germany (X tons) and France (X tons) held a minor share of total exports.

Ireland was also the fastest-growing in terms of the hormones, prostaglandins, thromboxanes and leukotrienes exports, with a CAGR of X% from 2012 to 2023. At the same time, Belgium (X%) displayed positive paces of growth. By contrast, Italy (X%), Spain (X%), Germany (X%) and France (X%) illustrated a downward trend over the same period. While the share of Ireland (X p.p.), Italy (X p.p.) and Belgium (X p.p.) increased significantly in terms of the total exports from 2012-2023, the share of Spain (X p.p.), Germany (X p.p.) and France (X p.p.) displayed negative dynamics.

In value terms, Ireland ($X) remains the largest hormones, prostaglandins, thromboxanes and leukotrienes supplier in the European Union, comprising X% of total exports. The second position in the ranking was held by Belgium ($X), with a X% share of total exports. It was followed by Germany, with a X% share.

From 2012 to 2023, the average annual rate of growth in terms of value in Ireland stood at X%. The remaining exporting countries recorded the following average annual rates of exports growth: Belgium (X% per year) and Germany (X% per year).

Export Prices by Country

In 2023, the export price in the European Union amounted to $X per kg, with a decrease of X% against the previous year. Overall, the export price saw a noticeable decline. The most prominent rate of growth was recorded in 2017 when the export price increased by X% against the previous year. As a result, the export price reached the peak level of $X per kg. From 2018 to 2023, the export prices remained at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Germany ($X per kg), while Spain ($X per kg) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Germany (X%), while the other leaders experienced more modest paces of growth.

Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

Imports in the EU

In 2023, purchases abroad of hormones, prostaglandins, thromboxanes and leukotrienes increased by X% to X tons, rising for the second year in a row after four years of decline. Overall, imports continue to indicate a buoyant increase. The most prominent rate of growth was recorded in 2017 when imports increased by X% against the previous year. As a result, imports reached the peak of X tons. From 2018 to 2023, the growth of imports remained at a lower figure.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports soared to $X in 2023. Total imports indicated a mild expansion from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, imports increased by X% against 2020 indices. Over the period under review, imports hit record highs at $X in 2017; however, from 2018 to 2023, imports stood at a somewhat lower figure.

Imports by Country

Italy prevails in imports structure, amounting to X tons, which was approx. X% of total imports in 2023. Spain (X tons), France (X tons), Belgium (X tons) and Germany (X tons) followed a long way behind the leaders.

Italy was also the fastest-growing in terms of the hormones, prostaglandins, thromboxanes and leukotrienes imports, with a CAGR of X% from 2012 to 2023. At the same time, Belgium (X%), Spain (X%) and Germany (X%) displayed positive paces of growth. By contrast, France (X%) illustrated a downward trend over the same period. Italy (X p.p.) significantly strengthened its position in terms of the total imports, while Germany, Spain and France saw its share reduced by X%, X% and X% from 2012 to 2023, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Italy ($X) constitutes the largest market for imported hormones, prostaglandins, thromboxanes and leukotrienes in the European Union, comprising X% of total imports. The second position in the ranking was held by Germany ($X), with a X% share of total imports. It was followed by Belgium, with a X% share.

In Italy, hormones, prostaglandins, thromboxanes and leukotrienes imports increased at an average annual rate of X% over the period from 2012-2023. In the other countries, the average annual rates were as follows: Germany (X% per year) and Belgium (X% per year).

Import Prices by Country

The import price in the European Union stood at $X per kg in 2023, shrinking by X% against the previous year. In general, the import price recorded a deep contraction. The growth pace was the most rapid in 2018 when the import price increased by X% against the previous year. The level of import peaked at $X per kg in 2014; however, from 2015 to 2023, import prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Germany ($X per kg), while Spain ($X per kg) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Belgium (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform